FDA 483 - Kelada Creative Group, LLC - February 01, 2019

An FDA inspection of Kelada Creative Group, LLC, a manufacturer of OTC and homeopathic drugs in Richmond, TX, revealed significant deficiencies in quality control. The firm failed to test raw materials, finished products, or conduct stability studies to determine expiration dates. Additionally, labeling errors were identified, indicating a systemic lack of quality assurance.